Daiwa Securities Group Inc. Pacific Biosciences Of California, Inc. Transaction History
Daiwa Securities Group Inc.
- $17.7 Billion
- Q1 2024
A detailed history of Daiwa Securities Group Inc. transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Daiwa Securities Group Inc. holds 225,792 shares of PACB stock, worth $295,787. This represents 0.0% of its overall portfolio holdings.
Number of Shares
225,792
Previous 909
24739.6%
Holding current value
$295,787
Previous $9,000
9300.0%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding PACB
# of Institutions
293Shares Held
253MCall Options Held
1.42MPut Options Held
1.18M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl33.3MShares$43.6 Million0.89% of portfolio
-
Vanguard Group Inc Valley Forge, PA26.6MShares$34.9 Million0.0% of portfolio
-
Black Rock Inc. New York, NY23.4MShares$30.6 Million0.0% of portfolio
-
Madrone Advisors, LLC Menlo Park, CA17.6MShares$23 Million9.04% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.12.8MShares$16.8 Million0.03% of portfolio
About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
- Ticker PACB
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 224,840,992
- Market Cap $295M
- Description
- Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...